Triple-Enzyme Mimetic Flexible-Interlaced Ferromagnetic Porous-Organic-Polymer for Self-Adaptive Antibacterial Cascade Therapy via Microenvironment-Reprogramming and Photosensitizer-Aggregation-Suppression
Source abstract
Abstract
The complex pathological microenvironment of infected wounds impedes antimicrobial efficacy while accelerating bacterial resistance. To overcome this, an oxygen-evolving polyphenol-based magnetic porous polymer (FcPor-POP) was engineered through the covalent conjugation of ferrocene-derived enzymatic units and photoactive polyphenol-porphyrin via phenolic-aldehyde condensation. The concurrently introducing antiquenching structural motifs, realized by flexible saturated carbon linkages, sandwich-like interleaved units, as well as a hydrogen-bond interlocked structure, effectively suppress photoactivity loss induced by π–π aggregation. The FcPor-POP system achieves adaptive antibacterial action through hierarchically coordinated spatiotemporal mechanisms. Pathological microenvironmental cues dynamically trigger enzymatic activity switching. Under acidic pH, the ferrocene units and in situ-formed Fe 3 O 4 nanoparticles exhibit peroxidase-like (POD) activity, converting H 2 O 2 to cytotoxic • OH (accelerated by photothermal heating). Upon H 2 O 2 depletion, oxidase-like (OXD) activity dominates, leveraging multivalent iron centers to produce O 2 •–, preserving enzyme-like antibacterial function. Targeted ROS delivery is enabled by phenolic hydroxyl groups that anchor to bacterial membranes via H-bonding, combined with rough surface topography enhancing physical adhesion. This minimizes the distance between ROS generation sites (Fe centers/photosensitizers) and bacterial targets, ensuring efficient membrane disruption by short-lived species. The polymer matrix orchestrates three cross-amplifying circuits. The catalase-like (CAT) activity decomposes H 2 O 2 into O 2, alleviating hypoxia while fueling the OXD and photodynamic therapy (PDT) in a self-reinforcing cycle. Photothermal cascades amplify all enzyme kinetics (POD/OXD/CAT) and directly damage pathogens. Microenvironment reprogramming occurs as in situ-formed Fe 3 O 4 consumes H + /H 2 O 2, elevating local pH to disrupt bacterial acid tolerance and reduce oxidative stress. This hierarchical coordination, where microenvironment sensing controls temporal enzyme switching, membrane targeting enables spatial ROS precision, and light-driven cascades (O 2 self-supply, PDT, PTT activation, and multienzyme synergy) optimize material/energy flow, establishes FcPor-POP as a dynamic therapeutic system with maximal antibacterial efficacy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Affiliated Hospital of Shandong Second Medical University
Shandong Second Medical University
School of Pharmacy
Shandong Neptunus Galaxy Pharmaceutical Co., Ltd
Comprehensive Treatment Room Outpatient Department
The Fourth Medical Center of Chinese PLA General Hospital
School of Life Sciences and Technology
Funding
Natural Science Foundation of Shandong Province
References (72)
Show source-provided references
1. 10.1016/j.cej.2021.12943110.1016/j.cej.2021.129431 ↗
2. 10.1039/D0RA09739J10.1039/D0RA09739J ↗
3. 10.1007/s00203-023-03826-z10.1007/s00203-023-03826-z ↗
4. 10.1038/s41579-024-01035-z10.1038/s41579-024-01035-z ↗
5. 10.1016/j.mib.2013.06.01310.1016/j.mib.2013.06.013 ↗
6. 10.3390/ijms23211365510.3390/ijms232113655 ↗
7. 10.1002/adma.20241897810.1002/adma.202418978 ↗
8. 10.1016/j.cej.2022.13714710.1016/j.cej.2022.137147 ↗
9. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
10. 10.1002/anie.20170114610.1002/anie.201701146 ↗
11. 10.1039/D1BM00317H10.1039/D1BM00317H ↗
12. 10.1039/C6TB02249A10.1039/C6TB02249A ↗
13. 10.1016/j.jcis.2021.12.07110.1016/j.jcis.2021.12.071 ↗
14. 10.1002/adhm.20240160910.1002/adhm.202401609 ↗
15. 10.1021/acsami.9b0435110.1021/acsami.9b04351 ↗
16. 10.1021/acsami.4c0499410.1021/acsami.4c04994 ↗
17. 10.1002/wnan.176910.1002/wnan.1769 ↗
18. 10.1038/s41467-018-06164-710.1038/s41467-018-06164-7 ↗
19. 10.1016/j.biotechadv.2024.10837610.1016/j.biotechadv.2024.108376 ↗
20. 10.1002/wnan.197910.1002/wnan.1979 ↗
21. 10.1038/s41467-024-50094-610.1038/s41467-024-50094-6 ↗
22. 10.1038/s41598-024-60824-x10.1038/s41598-024-60824-x ↗
23. 10.3390/molecules2905103910.3390/molecules29051039 ↗
24. 10.1039/D1CS01011E10.1039/D1CS01011E ↗
25. 10.1016/j.cis.2024.10323310.1016/j.cis.2024.103233 ↗
26. 10.1016/j.dyepig.2021.10913610.1016/j.dyepig.2021.109136 ↗
27. 10.1002/anie.20240083810.1002/anie.202400838 ↗
28. 10.3390/pharmaceutics1303029610.3390/pharmaceutics13030296 ↗
29. 10.1016/j.jddst.2024.10540910.1016/j.jddst.2024.105409 ↗
30. 10.1002/adfm.20210598910.1002/adfm.202105989 ↗
31. 10.1039/c3ta11934c10.1039/c3ta11934c ↗
32. 10.1039/C4RA12834F10.1039/C4RA12834F ↗
33. 10.1016/j.apsusc.2021.14945310.1016/j.apsusc.2021.149453 ↗
34. 10.1016/j.fuel.2018.06.01010.1016/j.fuel.2018.06.010 ↗
35. 10.1002/smll.20230085710.1002/smll.202300857 ↗
36. 10.1007/s10570-010-9481-z10.1007/s10570-010-9481-z ↗
37. 10.1063/5.016070010.1063/5.0160700 ↗
38. 10.1021/acs.jpcb.2c0493910.1021/acs.jpcb.2c04939 ↗
39. 10.3390/ma1518623710.3390/ma15186237 ↗
40. 10.1021/acs.est.1c0108510.1021/acs.est.1c01085 ↗
41. 10.1016/j.jhazmat.2017.08.04710.1016/j.jhazmat.2017.08.047 ↗
42. 10.1016/j.jmbbm.2016.10.00910.1016/j.jmbbm.2016.10.009 ↗
43. 10.1016/j.jallcom.2019.15233710.1016/j.jallcom.2019.152337 ↗
44. 10.1039/D2TB01015A10.1039/D2TB01015A ↗
45. 10.1016/j.carbon.2019.02.03310.1016/j.carbon.2019.02.033 ↗
46. 10.1016/j.apsusc.2020.14534510.1016/j.apsusc.2020.145345 ↗
47. 10.1016/j.jcou.2019.05.01610.1016/j.jcou.2019.05.016 ↗
48. 10.1016/j.inoche.2023.11135510.1016/j.inoche.2023.111355 ↗
49. 10.1016/j.mtbio.2021.10019810.1016/j.mtbio.2021.100198 ↗
50. 10.1039/C7CS00522A10.1039/C7CS00522A ↗
51. 10.1002/cssc.20240082910.1002/cssc.202400829 ↗
52. 10.1039/D4DT00650J10.1039/D4DT00650J ↗
53. 10.1093/mtomcs/mfac07010.1093/mtomcs/mfac070 ↗
54. 10.1016/j.msec.2018.12.01010.1016/j.msec.2018.12.010 ↗
55. 10.1021/acs.inorgchem.3c0078210.1021/acs.inorgchem.3c00782 ↗
56. 10.1021/acsnano.4c1027710.1021/acsnano.4c10277 ↗
57. 10.1021/acsami.8b2248710.1021/acsami.8b22487 ↗
58. 10.3390/ma1408193310.3390/ma14081933 ↗
59. 10.1021/acsnano.4c1226110.1021/acsnano.4c12261 ↗
60. 10.1002/adhm.20240239310.1002/adhm.202402393 ↗
61. 10.1016/j.cej.2022.13785510.1016/j.cej.2022.137855 ↗
62. 10.1021/jacs.4c0253010.1021/jacs.4c02530 ↗
63. 10.3390/antiox1102024410.3390/antiox11020244 ↗
64. 10.1038/s41467-022-33098-y10.1038/s41467-022-33098-y ↗
65. 10.3390/molecules2720713610.3390/molecules27207136 ↗
66. 10.1039/D4MD00002A10.1039/D4MD00002A ↗
67. 10.3390/pharmaceutics1507189310.3390/pharmaceutics15071893 ↗
68. 10.3390/foods1207136110.3390/foods12071361 ↗
69. 10.1002/adhm.20210077510.1002/adhm.202100775 ↗
70. 10.1016/j.jmst.2023.04.00510.1016/j.jmst.2023.04.005 ↗
71. 10.1016/j.jcis.2018.05.02410.1016/j.jcis.2018.05.024 ↗
72. 10.1016/j.pdpdt.2022.10301110.1016/j.pdpdt.2022.103011 ↗